WGS
Income statement / Annual
Last year (2025), GeneDx Holdings Corp's total revenue was $427.54 M,
an increase of 39.97% from the previous year.
In 2025, GeneDx Holdings Corp's net income was -$21.02 M.
See GeneDx Holdings Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$427.54 M |
$305.45 M |
$202.57 M |
$234.69 M |
$212.20 M |
$179.32 M |
$196.17 M |
| Cost of Revenue |
$129.37 M
|
$111.05 M
|
$112.56 M
|
$261.44 M
|
$228.80 M
|
$175.30 M
|
$113.39 M
|
| Gross Profit |
$298.17 M
|
$194.40 M
|
$90.01 M
|
-$26.75 M
|
-$16.60 M
|
$4.03 M
|
$82.79 M
|
| Gross Profit Ratio |
0.7
|
0.64
|
0.44
|
-0.11
|
-0.08
|
0.02
|
0.42
|
| Research and Development Expenses |
$72.03 M
|
$45.72 M
|
$58.27 M
|
$86.20 M
|
$105.16 M
|
$72.70 M
|
$34.91 M
|
| General & Administrative Expenses |
$150.82 M
|
$101.11 M
|
$133.76 M
|
$216.17 M
|
$205.99 M
|
$100.74 M
|
$29.48 M
|
| Selling & Marketing Expenses |
$88.41 M
|
$67.37 M
|
$60.96 M
|
$122.08 M
|
$112.74 M
|
$63.18 M
|
$39.35 M
|
| Selling, General & Administrative Expenses |
$239.22 M
|
$168.48 M
|
$194.71 M
|
$338.24 M
|
$318.73 M
|
$163.93 M
|
$68.84 M
|
| Other Expenses |
$0.00
|
$3.41 M
|
$17.63 M
|
$216.46 M
|
$5.66 M
|
$9.40 M
|
$9.45 M
|
| Operating Expenses |
$311.25 M
|
$217.61 M
|
$270.60 M
|
$640.90 M
|
$429.55 M
|
$246.02 M
|
$113.20 M
|
| Cost And Expenses |
$439.34 M
|
$328.66 M
|
$383.16 M
|
$902.35 M
|
$658.34 M
|
$421.32 M
|
$226.59 M
|
| Interest Income |
$0.00
|
$0.00
|
$1.11 M
|
$2.54 M
|
$79.00 K
|
$506.00 K
|
$988.00 K
|
| Interest Expense |
$2.54 M
|
$3.03 M
|
$0.00
|
$3.21 M
|
$2.84 M
|
$2.47 M
|
$783.00 K
|
| Depreciation & Amortization |
$25.22 M
|
$21.95 M
|
$33.73 M
|
$59.31 M
|
$21.81 M
|
$11.73 M
|
$6.41 M
|
| EBITDA |
$6.63 M |
-$1.26 M |
-$136.46 M |
-$398.20 M |
-$220.75 M |
-$227.13 M |
-$22.51 M |
| EBITDA Ratio |
0.02
|
-0
|
-0.67
|
-1.7
|
-1.04
|
-1.27
|
-0.11
|
| Operating Income Ratio |
-0.03
|
-0.08
|
-0.89
|
-2.84
|
-2.1
|
-1.35
|
-0.16
|
| Total Other Income/Expenses Net |
-$9.34 M
|
-$29.42 M
|
$3.90 M
|
$69.62 M
|
$200.76 M
|
$654.00 K
|
$709.00 K
|
| Income Before Tax |
-$21.14 M
|
-$52.63 M
|
-$176.69 M
|
-$598.03 M
|
-$245.39 M
|
-$241.34 M
|
-$29.70 M
|
| Income Before Tax Ratio |
-0.05
|
-0.17
|
-0.87
|
-2.55
|
-1.16
|
-1.35
|
-0.15
|
| Income Tax Expense |
-$116.00 K
|
-$343.00 K
|
-$926.00 K
|
-$49.05 M
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$21.02 M
|
-$52.29 M
|
-$175.77 M
|
-$548.98 M
|
-$245.39 M
|
-$241.34 M
|
-$29.70 M
|
| Net Income Ratio |
-0.05
|
-0.17
|
-0.87
|
-2.34
|
-1.16
|
-1.35
|
-0.15
|
| EPS |
-0.73 |
-1.94 |
-7.23 |
-53.63 |
-74.93 |
-33.16 |
-4.26 |
| EPS Diluted |
-0.73 |
-1.94 |
-7.23 |
-53.63 |
-74.93 |
-146.94 |
-18.48 |
| Weighted Average Shares Out |
$26.89 M
|
$26.89 M
|
$24.31 M
|
$10.24 M
|
$3.28 M
|
$5.63 M
|
$5.63 M
|
| Weighted Average Shares Out Diluted |
$26.89 M
|
$26.89 M
|
$24.31 M
|
$10.24 M
|
$3.28 M
|
$5.63 M
|
$5.63 M
|
| Link |
|
|
|
|
|
|
|
